- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
21 Cards in this Set
- Front
- Back
|
Antiviral tx strategies
|
Stop immunosuppression, IVIg (good for parvovirus, CMV, rabies), and antivirals.
|
|
Viral replication
|
Attaches and goes into vesicle where is disassembles. The genome is exposed and goes to nucleus (DNA) or cytoplasm (RNA) where it is duplicated.
Then protein virion goes to membrane and gets out and infects other cells. |
|
Target and activity of nucleoside and NT analogs
|
DNA replication; herpes, HBV, HCV and HIV
|
|
Target and activity of Neuraminidase inhibitors
|
release of virions; influenza
|
|
Target and activity of interferon alpha
|
immune response; HBV and HCV
|
|
Acyclovir - MOAction
|
Nucleoside analog
Against wide range of herpes viruses. Analog of guanosine that needs thymidine kinase to activate it (present in herpes viruses except CMV). Then it inhibits herpes DNA polym because the phopsphorylated acyclovir incorps into the DNA chain and terminates it. |
|
pharmacokin of acyclovir
|
oral and IV but poorly absorpbed orally.
so if a serious ifnection, need the IV form. |
|
Ganciclovir
|
Nucleoside analog
Good against CMV as well because it doesnt need virus-provided thymidine kinase for activation. Resistance is a big issue with this one. |
|
Spectrum of acyclovir and gancyclovir
|
Acyclovir - HSV1, 2, varicella zoster.
Gancyclovir - HSV1, 2, varicella zoster, CMV. |
|
Tx of influenza (prophylaxis and tx)
|
M2 inhibitors (amantadine and rimantadine) - Good for A only
or neuraminidase inhibitors (Zamamivir or oseltamivir) - For A and B |
|
M2 channel inhibitors
|
Amantadine and rimantadine
prevent uncoating and release of genome of the viruses. |
|
Neuraminidase inhibitors
|
Zamamivir and oseltamivir
Prevent release of the virus from the membrane into the extracellular env (by inhibiting neuraminidase - the enzyme that allows this...) |
|
Viruses causing hepatitis than can be helped with antivirals
|
Hep B, C and CMV
|
|
Hep B
|
Much higher risk of hepatocellular CA. If it gets infants, more risk of being a chronic carrier.
Use pegylated interferon (long acting and high blood levels) or oral drugs (analogs) |
|
HBV replication
|
complex. Can be normal classic dogma or reverse txpn
|
|
Interferon for Hep b
|
subcut. Very toxic but no resistrance.
|
|
analogs of Hep B
|
nucleoside - lamivudine, entecavir, telbivudine
NT - adefovir and tenofovir oral, well tolerated but there is both resistance and cross-resistance. |
|
endpoints to monitor for HBV success of therapy
|
HBeAg loss and seroconversion to HBeAb positive
HBsAg loss and HBsAb seroconversion (this is pretty rare) Less HBV viral load (DNA) Histological improvement. |
|
Signs of good px of HBV treatment
|
less DNA, ALT normalization, improvement in histology, HBeAg-->HBeAb and HBsAg-->HBsAb
|
|
Tx of chronic hep C
|
pegylated alpha interferon and ribavirin (which is a guanosine analog that inhibits viral RNA binding to ribosomes)
use both of these together (in contrast to tx of HBV) |
|
signs of good px in tx of HCV
|
drop in HCV viral load, normalization of LFTs, better histology
|